The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -2.31%. However, over the last six months, the performance has been weaker by 3.46%. The price of BEAM increased 1.10% over the last 30 days. And in the last five days, it has surged by 13.68%.
Beam Therapeutics Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $49.50 on 02/27/24, while the lowest price for the same duration was marked at $16.95 on 10/23/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of BEAM Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Beam Therapeutics Inc’s current trading price is -46.28% away from its 52-week high, while its distance from the 52-week low is 56.87%. The stock’s price range during this period has varied between$16.95 and $49.50. The Beam Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.37 million for the day, a figure considerably higher than their average daily volume of 0.95 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Beam Therapeutics Inc (BEAM) has experienced a quarterly decline of -2.57% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.19B and boasts a workforce of 436 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 25.21, with a change in price of +1.79. Similarly, Beam Therapeutics Inc recorded 1,067,499 in trading volume during the last 100 days, posting a change of +7.22%.
BEAM’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BEAM stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.18.
BEAM Stock Stochastic Average
Beam Therapeutics Inc’s raw stochastic average for the past 50 days is presently 78.61%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 90.20%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 50.53% and 31.63%, respectively.
